Ads
related to: Pharmaceutical Products Development llc- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Chemical Synthesis
Organic Building Blocks, Catalysts,
Heterocycles, Ligands, and more.
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Sign In
Search results
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Decline in Short Interest
ETF DAILY NEWS· 4 days agoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) was the target of a significant decrease in short interest in April. As of April 30th, there was short interest ...
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into...
WPRI Providence· 7 days ago(OTC: CATV) announced today the execution of a Letter of Intent (LOI) to acquire Genetic Networks, LLC (https://geneticnetworks.com/), a leader in applied molecular biology ...
Short Interest in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Rises By 16.5%
ETF DAILY NEWS· 6 days agoLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the target of a large increase in short interest in April. As of April 30th, there was short interest totalling ...
Stephen F. Betz Sells 3,000 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stock
ETF DAILY NEWS· 6 days agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) insider Stephen F. Betz sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, May ...
StockNews.com Upgrades Syros Pharmaceuticals (NASDAQ:SYRS) to Hold
ETF DAILY NEWS· 5 days agoSyros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Wednesday.
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Digital Journal· 6 days agoLaxxon's IP is continuously growing and consists of 150 patents and patent applications with more than 3,000 patent claims...AI Alliance CoTec Holdings Corp. Subsidiary HyProMag USA
StockNews.com Initiates Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS)
ETF DAILY NEWS· 5 days agoStockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on ...
Syros Pharmaceuticals (NASDAQ:SYRS) Upgraded by StockNews.com to Hold
ETF DAILY NEWS· 6 days agoStockNews.com upgraded shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday ...
Earnings call: NRx Pharmaceuticals outlines strategic growth and clinical advances By Investing.com
Investing.com· 7 days agoNRx Pharmaceuticals (NRXP) reported a reduction in net loss and advancements in their clinical...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 3 days agoHC Wainwright restated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently ...